Gene · 6439
Papers3,679
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 3,679
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidized Low-Density Lipoprotein (Ox-LDL) and Triggering Receptor-Expressed Myeloid Cell (TREM-1) Levels Are Associated with Cardiometabolic Risk in Nonobese, Clinically Healthy, and Young Adults. | Oxid Med Cell Longev | 2019 | 30944697 | PubTator, text mining | PubMed |
| Altered Surfactant Protein Expression in Primary Acquired Nasolacrimal Duct Obstruction. | Ophthalmic Plast Reconstr Surg | 2019 | 30882588 | PubTator, text mining | PubMed |
| Immature surfactant protein-B impairs the antioxidant capacity of HDL. | Int J Cardiol | 2019 | 30857841 | PubTator, text mining | PubMed |
| A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia. | Hum Genome Var | 2019 | 30854216 | PubTator, text mining | PubMed |
| Histopathologic and Genetic Features of Alveolar Capillary Dysplasia with Atypical Late Presentation and Prolonged Survival. | J Pediatr | 2019 | 30853201 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system. | Cell Signal | 2019 | 30849519 | PubTator, text mining | PubMed |
| Lipophilic Allergens, Different Modes of Allergen-Lipid Interaction and Their Impact on Asthma and Allergy. | Front Immunol | 2019 | 30837983 | PubTator, text mining | PubMed |
| Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer. | Cancers (Basel) | 2019 | 30832375 | PubTator, text mining | PubMed |
| Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases. | Drug Deliv | 2019 | 30822171 | PubTator, text mining | PubMed |
| Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics. | Front Pediatr | 2019 | 30815432 | PubTator, text mining | PubMed |
| Surfactant proteins: Role in lacrimal drainage disorders. | Med Hypotheses | 2019 | 30798912 | PubTator, text mining | PubMed |
| SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. | Mov Disord | 2019 | 30788890 | PubTator, text mining | PubMed |
| Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer. | J Cardiovasc Dev Dis | 2019 | 30781363 | PubTator, text mining | PubMed |
| Organic dust inhibits surfactant protein expression by reducing thyroid transcription factor-1 levels in human lung epithelial cells. | Innate Immun | 2019 | 30774012 | PubTator, text mining | PubMed |
| In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. | Stem Cell Reports | 2019 | 30773483 | PubTator, text mining | PubMed |
| Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury. | Int J Mol Sci | 2019 | 30769918 | PubTator, text mining | PubMed |
| Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson's Disease. | Pharmaceuticals (Basel) | 2019 | 30764521 | PubTator, text mining | PubMed |
| Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future. | Korean J Pediatr | 2019 | 30744318 | PubTator, text mining | PubMed |
| Induced pluripotent stem cells in disease modelling and drug discovery. | Nat Rev Genet | 2019 | 30737492 | PubTator, text mining | PubMed |
| Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. | J Exp Med | 2019 | 30737256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6439/papers?page=70